Navigation Links
Opium and marijuana research go underground
Date:10/31/2007

The worlds leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant cannabis in hopes of finding new uses for the much-maligned sources of heroin and marijuana.

Peter Facchini, professor of Biological Sciences and Canada Research Chair in Plant Biotechnology, has received a $650,000 NSERC Strategic Project Grant to create new varieties of opium poppy and cannabis that can be used for medicinal and industrial purposes, but will have no value as illicit drugs. And his work is taking him where few Canadians have gone before: Deep underground into the countrys ultra high-security medicinal marijuana growth facility.

Its certainly unusual for a plant biochemist to work in a copper mine hundreds of metres underground, Facchini said. This is a really great project that involves two of the worlds most important medicinal plants and is clearly unique in the plant biology field.

Facchini and a new team of U of C postdoctoral researchers have teamed up with Saskatoon-based Prairie Plant Systems Inc., the National Research Council Plant Biotechnology Institute, the Alberta Research Council and the University of Saskatchewan to create and study mutant varieties of opium poppy and cannabis in an unused portion of a copper and zinc mine near Flin Flon, Manitoba. Prairie Plant Systems produces medicinal marijuana under contract with Health Canada in this state-of-the-art facility.

Despite awareness of the importance of crop diversification for the long-term success of agriculture in Canada, few plants are cultivated for the production of high-value bioproducts. Opium poppy accumulates the alkaloids morphine, codeine and thebaine, and cannabis produces psychoactive cannabinoids and is used as a source of high-quality fiber and oil. The domestic market for codeine, morphine and oxycodone, which is derived from thebaine, is in excess of $1.6 billion annually, all of which is currently imported. Canada is well-positioned to support the development of new crops cultivated for the production of valuable bioproducts, such as pharmaceuticals and fibers, says Facchini. The research will identify novel genes for use in the metabolic engineering of opium poppy to accumulate high-value pharmaceutical alkaloids and to block cannabinoid production in cannabis. The latter will allow for a safe, legal, made-in-Canada cannabis crop that will have virtually none of the mind-altering chemical of marijuana but can be grown for hemp fibre, oil and food.

The overall theme of this work is to modify plants to make them more useful as crops and chemical factories, Facchini said. Alberta is quickly becoming a leader in this area, especially in the area of biofuels. The immense potential of plants as sources of high-value bioproducts for the agricultural and pharmaceutical sectors also needs attention.

The Biosecure Underground Growth Chamber is in a mine owned by Hudson Bay Smelting & Mining Co. Ltd. Facchini says it is a superb venue for his research. Its not what you would picture an old mine shaft to be. Its clean and well-lit, its kept at a constant temperature and its one of the most secure places in the country, he says. It gives a whole new meaning to mining our data.


'/>"/>

Contact: Grady Semmens
gsemmens@ucalgary.ca
403-220-7722
University of Calgary
Source:Eurekalert

Related biology news :

1. Canada approves marijuana-based pain spray
2. Scientists discover the bodys marijuana-like compounds are crucial for stress-induced pain relief
3. Good news for the medical marijuana movement: pot proliferates brain cells and boosts mood
4. Machinery of the marijuana munchies
5. Marijuana-like compounds suppress the immune response
6. New DNA fingerprinting technique separates hemp from marijuana
7. Long-term marijuana smoking leads to respiratory complaints
8. Enhancing activity of marijuana-like chemicals in brain helps treat
9. New study examines brains own marijuana
10. Researchers discover way to make cells in the eye sensitive to light
11. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... , ... Global Stem Cells Group CEO Benito Novas announced that ... GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in ... hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM Professor ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, ... bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., ... A round of financing. Healthy investor interest drove significant oversubscription of the original ... biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and ...
(Date:4/26/2016)... 26, 2016 genae, a Contract ... industries, announced today the appointment of Prof. Dr. Jörn ... Balzer,s responsibilities will include all clinical, safety and risk ... feel privileged and honored with the acceptance of Prof. ... , CEO at genae. "Prof. Balzer,s impressive and extensive ...
Breaking Biology Technology: